SEC Filing Summary: Healthcare Acquisition Corp. (8-K)
Business Context and Reporting Period
This Form 8-K was filed by Healthcare Acquisition Corp. on October 3, 2005, reporting events occurring on October 6, 2005. The company is a Delaware corporation that consummated its initial public offering on August 3, 2005. Note: The request metadata references "Altimmune, Inc.", but the filing text explicitly identifies the registrant as "Healthcare Acquisition Corp."
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses on corporate governance and trading structure changes rather than financial performance data.
Material Changes
- Separate Trading: Commencing October 6, 2005, the common stock and warrants included in the Company's units will trade separately.
- Cessation of Unit Trading: Trading in the combined units will cease on October 6, 2005.
- Listing Symbols: Common stock will trade under the symbol HAQ and warrants under HAQ.WS on the American Stock Exchange.
Guidance, Outlook, and Risks
The filing contains no management commentary regarding future financial guidance, outlook, risks, contingencies, or unusual items. The document is strictly a notification of the separation of trading instruments.
Investor Verification Checklist
- Verify the correct registrant name is Healthcare Acquisition Corp., not Altimmune, Inc.
- Confirm the effective date of separate trading (October 6, 2005) for portfolio adjustments.
- Check the American Stock Exchange for the new ticker symbols (HAQ and HAQ.WS).
- Review the press release (Exhibit 99.1) for additional details on the separation mechanics.